Sponsored Webcast: Discussing Regulatory Affairs: Leadership Perspectives & 2024 Survey Insights (On Demand)

Member: $0 | Nonmember: $50
Get fresh insights from industry leaders on key challenges, opportunities, and tech in regulatory affairs from the 2024 RAPS-Celegence industry survey. Compare to your organization and learn new strategies.

Qualio

Join the discussion to hear industry leaders and share key insights and learnings from the recent survey that was conducted across the life sciences industry from RAPS in partnership with Celegence.

This thought-provoking session will explore the findings and insights on the top challenges and opportunities for regulatory professionals, planned investments near and long term, and alignment to changing technology such as real artificial intelligence use cases. The session will look at maturity scales such as readiness for IDMP (Identification of Medicinal Products), efficiency in publications and submission including plans for eCTD v4.0 (Electronic Common Technical Document), use of document management systems and evolving practices in medical writing. 

Our presenters will dive deeper into what this means for pharma companies today and what to expect over the next two years. The full report will be provided to participants with the webinar unpacking the details and sharing the story behind the numbers such as how pharma companies can do more given pressure on resources and bandwidth to stay ahead on compliance.

Register now for this unique opportunity to get the latest insights and hear from industry leaders sharing their perspectives on some of the more surprising results.

Registration Fees & Deadlines

Member: $0 | Nonmember: $50

Learning Objectives

  • Get a pulse on the latest trends in regulatory affairs for pharma and medical devices
  • Compare top challenges, pain points and shifts in skills, process and technology
  • Explore specific perspectives on medical writing, IDMP, eCTD v4.0
  • See future investment areas in pharma related to regulatory and compliance
  • Discover real AI use cases in regulatory affairs and operations

Who Should Attend?

  • VP, Director in Regulatory Affairs
  • VP, Director in Regulatory Operations
  • VP, Director in Electronic submissions
  • VP, Director in Medical Affairs
  • VP, Director or head of Quality

Audience Learning Level

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Speaker

Leslie Cort

Sonia Veluchamy
CEO, Celegence

Stephanie Seidel

Punya Abbhi
COO, Celegence

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.